WallStSmart

Aspire BioPharma, Inc. (ASBP)vsMagna International Inc (MGA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Magna International Inc generates 43693328% more annual revenue ($42.67B vs $97,660). MGA leads profitability with a 1.8% profit margin vs 0.0%. MGA earns a higher WallStSmart Score of 64/100 (C+).

ASBP

Avoid

22

out of 100

Grade: F

Growth: 4.3Profit: 4.5Value: 5.0Quality: 5.3
Piotroski: 3/9Altman Z: -83.49

MGA

Buy

64

out of 100

Grade: C+

Growth: 5.3Profit: 5.0Value: 8.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ASBP.

MGAUndervalued (+46.7%)

Margin of Safety

+46.7%

Fair Value

$108.43

Current Price

$63.99

$44.44 discount

UndervaluedFair: $108.43Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASBP1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

MGA3 strengths · Avg: 9.3/10
PEG RatioValuation
0.3610/10

Growing faster than its price suggests

Price/BookValuation
1.5x10/10

Reasonable price relative to book value

EPS GrowthGrowth
27.8%8/10

Earnings expanding 27.8% YoY

Areas to Watch

ASBP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$11.80M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

MGA4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.3%4/10

3.3% revenue growth

Return on EquityProfitability
6.4%3/10

ROE of 6.4% — below average capital efficiency

Profit MarginProfitability
1.8%3/10

1.8% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : ASBP

The strongest argument for ASBP centers on Price/Book.

Bull Case : MGA

The strongest argument for MGA centers on PEG Ratio, Price/Book, EPS Growth. PEG of 0.36 suggests the stock is reasonably priced for its growth.

Bear Case : ASBP

The primary concerns for ASBP are Revenue Growth, EPS Growth, Market Cap.

Bear Case : MGA

The primary concerns for MGA are Revenue Growth, Return on Equity, Profit Margin. Thin 1.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

MGA carries more volatility with a beta of 1.81 — expect wider price swings.

MGA is growing revenue faster at 3.3% — sustainability is the question.

MGA generates stronger free cash flow (654M), providing more financial flexibility.

Monitor AUTO PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MGA scores higher overall (64/100 vs 22/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aspire BioPharma, Inc.

CONSUMER CYCLICAL · AUTO PARTS · USA

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.

Visit Website →

Magna International Inc

CONSUMER CYCLICAL · AUTO PARTS · USA

Magna International Inc. designs, designs and manufactures components, assemblies, systems, subsystems and modules for vehicle and light truck original equipment manufacturers worldwide. The company is headquartered in Aurora, Canada.

Want to dig deeper into these stocks?